Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

News
High Number of Nevi, Genetic Predisposition Associated With Risk for Development of Second Primary Melanomas
12/15/2022
A study identified specific factors present in patients that may indicate higher risk for the development of second primary melanomas.
A study identified specific factors present in patients that may indicate higher risk for the development of second primary melanomas.
A study identified specific...
12/15/2022
Oncology
Quiz: Prognostic Efficacy of Electronic Total Tumor Infiltrating Lymphocytes
11/30/2022
What was determined to be the best practice for using total tumor-inflitrating lymphocytes to predict disease outcome in melanoma patients?
What was determined to be the best practice for using total tumor-inflitrating lymphocytes to predict disease outcome in melanoma patients?
What was determined to be the...
11/30/2022
Oncology
News
Electronic Total Tumor-Infiltrating Lymphocytes Predict Risk of Relapse in Patients With Melanoma
11/18/2022
Study findings demonstrate the efficacy of electronic total tumor-infiltrating lymphocytes for predicting potential relapse prognoses in patients with melanoma.
Study findings demonstrate the efficacy of electronic total tumor-infiltrating lymphocytes for predicting potential relapse prognoses in patients with melanoma.
Study findings demonstrate the...
11/18/2022
Oncology
Quiz
True or False: Combination nivolumab-ipilimumab response rate worse in patients not treated with immunotherapy than in patients previously treated with immunotherapy.
11/09/2022
Did a phase 2 trial find better response rates to treatment with combination nivolumab-ipilimumab among patients who had previously received cancer immunotherapy as treatment or patients who had not previously been treated with a single-agent...
Did a phase 2 trial find better response rates to treatment with combination nivolumab-ipilimumab among patients who had previously received cancer immunotherapy as treatment or patients who had not previously been treated with a single-agent...
Did a phase 2 trial find better...
11/09/2022
Oncology
Quiz
True or False: The en face freezing technique of tumor excision is an acceptable alternative to Mohs micrographic surgery (MMS)?
10/05/2022
According to a study in the Anais brasileiros de dermatologia, is the en face freezing technique of tumor excision a reliable alternative to MMS?
According to a study in the Anais brasileiros de dermatologia, is the en face freezing technique of tumor excision a reliable alternative to MMS?
According to a study in the...
10/05/2022
Oncology
“En Face” Freezing Proves Reliable, Safe in Reduction of Tumor Relapse in Patients With Skin Carcinomas
09/20/2022
Use of the “en face” freezing technique yields low tumor relapse and guarantees negative surgical margins for patients with skin carcinomas.
Use of the “en face” freezing technique yields low tumor relapse and guarantees negative surgical margins for patients with skin carcinomas.
Use of the “en face” freezing...
09/20/2022
Oncology
Quiz
Quiz: Instances of Melanoma Detection in Physician-Based Screening for Skin Cancer
08/29/2022
According to a study published in the British Journal of Dermatology, accounting for known risk factors, how do melanoma detection rates among patients screened for skin cancer by a physician compare to those not undergoing screening?
According to a study published in the British Journal of Dermatology, accounting for known risk factors, how do melanoma detection rates among patients screened for skin cancer by a physician compare to those not undergoing screening?
According to a study published...
08/29/2022
Oncology
News
Using Risk Factors for Metastasis to Improve Cutaneous Squamous Cell Carcinoma Staging Systems
08/09/2022
Retrospective study aims to identify variables for significant risk of metastasis in patients with cutaneous squamous cell carcinoma.
Retrospective study aims to identify variables for significant risk of metastasis in patients with cutaneous squamous cell carcinoma.
Retrospective study aims to...
08/09/2022
Oncology
Quiz
Quiz: What Proportion of Patients Receiving Treatment for Severe Acitinic Keratoses Develop Invasive Cutaneous Squamous Cell Carcinoma?
07/25/2022
In a secondary analysis in a multicenter clinical trial across 4 hospitals in the Netherlands, what fraction of patients who need additional treatment for severe actinic keratoses experienced increased risk of subsequent invasive cSCC?
In a secondary analysis in a multicenter clinical trial across 4 hospitals in the Netherlands, what fraction of patients who need additional treatment for severe actinic keratoses experienced increased risk of subsequent invasive cSCC?
In a secondary analysis in a...
07/25/2022
Oncology
Quiz
Quiz: Do Beta Blockers Impact Efficacy of Pembrolizumab in Resected High-Risk Melanoma?
07/13/2022
Did patients with melanoma in the KEYNOTE-054 trial who received β-blockers and pembrolizumab experience significantly improved recurrence free survival compared to those not using b-blockers?
Did patients with melanoma in the KEYNOTE-054 trial who received β-blockers and pembrolizumab experience significantly improved recurrence free survival compared to those not using b-blockers?
Did patients with melanoma in...
07/13/2022
Oncology
News
Epigallocatechin-3-Gallate Plus Radiotherapy Reduces Radiation-Induced Dermatitis in Patients With Breast Cancer
06/14/2022
Epigallocatechin-3-gallate plus radiotherapy reduced radiation-induced dermatitis vs radiotherapy alone among patients with breast cancer in a phase 2 study.
Epigallocatechin-3-gallate plus radiotherapy reduced radiation-induced dermatitis vs radiotherapy alone among patients with breast cancer in a phase 2 study.
Epigallocatechin-3-gallate plus...
06/14/2022
Oncology
News
Reflectance Confocal Microscopy Reduces Unnecessary Excision and Assures Removal of Aggressive Melanomas
06/13/2022
Adjunctive use of reflectance confocal microscopy for suspect lesions reduces unnecessary excisions and assures the removal of aggressive melanomas.
Adjunctive use of reflectance confocal microscopy for suspect lesions reduces unnecessary excisions and assures the removal of aggressive melanomas.
Adjunctive use of reflectance...
06/13/2022
Oncology
News
Beta Blockers Provide No Prognostic Value Among Patients With Resected, High-Risk Melanoma
06/02/2022
Study findings suggest beta blockers provide no prognostic effect on recurrence-free survival among patients with resected, high-risk melanoma in the KEYNOTE-054 trial.
Study findings suggest beta blockers provide no prognostic effect on recurrence-free survival among patients with resected, high-risk melanoma in the KEYNOTE-054 trial.
Study findings suggest beta...
06/02/2022
Oncology
News
Possible Overdiagnosis of Melanoma Among Individuals Who Undergo Skin Screening
05/25/2022
Researchers aimed to assess possible overdiagnosis by comparing subsequent melanoma incidence and biopsy rates among individuals subjected to skin screening vs those who were not.
Researchers aimed to assess possible overdiagnosis by comparing subsequent melanoma incidence and biopsy rates among individuals subjected to skin screening vs those who were not.
Researchers aimed to assess...
05/25/2022
Oncology
News
Severe Actinic Keratoses Associated With Increased Risk of Squamous Cell Carcinoma
05/11/2022
Study findings identify severe actinic keratoses as a marker for increased incidence of cutaneous squamous cell carcinoma; this risk was substantially increased in patients who received additional treatment.
Study findings identify severe actinic keratoses as a marker for increased incidence of cutaneous squamous cell carcinoma; this risk was substantially increased in patients who received additional treatment.
Study findings identify severe...
05/11/2022
Oncology
News
Skin Cancer Education for Cosmetologists Could Bolster Detection of Suspicious Lesions
11/25/2020
Study findings suggest that by including skin cancer content in cosmetology curricula, cosmetologists can be better screen their clients for suspicious lesions.
Study findings suggest that by including skin cancer content in cosmetology curricula, cosmetologists can be better screen their clients for suspicious lesions.
Study findings suggest that by...
11/25/2020
Oncology
News
DNA Alterations Can Predict Risk for Melanoma Earlier
10/08/2020
According to A. Hunter Shain, PhD, and colleagues, melanoma can be predicted long before any suspicious moles are detected thanks to the identification of DNA mutations in individual skin cells.
According to A. Hunter Shain, PhD, and colleagues, melanoma can be predicted long before any suspicious moles are detected thanks to the identification of DNA mutations in individual skin cells.
According to A. Hunter Shain,...
10/08/2020
Oncology
Measuring Immune Checkpoint Inhibition Efficacy via Treatment-Free Survival in Advanced Melanoma
Commentary
Measuring Immune Checkpoint Inhibition Efficacy via Treatment-Free Survival in Advanced Melanoma
04/20/2020
Experts are developing a novel clinical trial outcome measure to characterize the antitumor activity of ICI protocol therapy in advanced melanoma.
Experts are developing a novel clinical trial outcome measure to characterize the antitumor activity of ICI protocol therapy in advanced melanoma.
Experts are developing a novel...
04/20/2020
Oncology
News
Immune Checkpoint Inhibitor Type, Dose Influence Risk for AEs in Melanoma
04/09/2020
A review of randomized trials in patients with advanced melanoma showed that the risk for immune-related AEs varies based on immune checkpoint inhibitor type and dose.
A review of randomized trials in patients with advanced melanoma showed that the risk for immune-related AEs varies based on immune checkpoint inhibitor type and dose.
A review of randomized trials in...
04/09/2020
Oncology
News
Nomogram Could Help Select Patients With Melanoma to Undergo Biopsies
04/01/2020
Researchers propose using an externally validated nomogram to better select patients with T1 melanoma to undergo sentinel node biopsy.
Researchers propose using an externally validated nomogram to better select patients with T1 melanoma to undergo sentinel node biopsy.
Researchers propose using an...
04/01/2020
Oncology
News
Study Findings Stress Importance of Primary Tumor Mitotic Rate in Melanoma
02/10/2020
Study findings highlight the importance of the primary tumor mitotic rate, and provide a framework for evidence-based surveillance of CNS metastasis in stage III melanoma.
Study findings highlight the importance of the primary tumor mitotic rate, and provide a framework for evidence-based surveillance of CNS metastasis in stage III melanoma.
Study findings highlight the...
02/10/2020
Oncology
Interview
Monitoring Ipilimumab Response in Patients with Metastatic Melanoma
05/07/2019
Wolfgang Weber, MD, discusses the link between tumor response on 18F-FDG PET/CT and prognosis in patients treated with ipilimumab.
Wolfgang Weber, MD, discusses the link between tumor response on 18F-FDG PET/CT and prognosis in patients treated with ipilimumab.
Wolfgang Weber, MD, discusses...
05/07/2019
Oncology
Interview
First-Line Pembrolizumab Yields Robust Tumor Control, Favorable OS Over Chemo in Advanced MCC
02/13/2019
"Recent advances in our understanding of the human immune system and how it has the capacity to fight off and destroy cancer...has been nothing short of groundbreaking," says Dr Riker.
"Recent advances in our understanding of the human immune system and how it has the capacity to fight off and destroy cancer...has been nothing short of groundbreaking," says Dr Riker.
"Recent advances in our...
02/13/2019
Oncology

Advertisement

Advertisement

Advertisement

Recent News

News
High Number of Nevi, Genetic Predisposition Associated With Risk for Development of Second Primary Melanomas
12/15/2022
A study identified specific factors present in patients that may indicate higher risk for the development of second primary melanomas.
A study identified specific factors present in patients that may indicate higher risk for the development of second primary melanomas.
A study identified specific...
12/15/2022
Oncology
News
Electronic Total Tumor-Infiltrating Lymphocytes Predict Risk of Relapse in Patients With Melanoma
11/18/2022
Study findings demonstrate the efficacy of electronic total tumor-infiltrating lymphocytes for predicting potential relapse prognoses in patients with melanoma.
Study findings demonstrate the efficacy of electronic total tumor-infiltrating lymphocytes for predicting potential relapse prognoses in patients with melanoma.
Study findings demonstrate the...
11/18/2022
Oncology
News
Using Risk Factors for Metastasis to Improve Cutaneous Squamous Cell Carcinoma Staging Systems
08/09/2022
Retrospective study aims to identify variables for significant risk of metastasis in patients with cutaneous squamous cell carcinoma.
Retrospective study aims to identify variables for significant risk of metastasis in patients with cutaneous squamous cell carcinoma.
Retrospective study aims to...
08/09/2022
Oncology
News
Epigallocatechin-3-Gallate Plus Radiotherapy Reduces Radiation-Induced Dermatitis in Patients With Breast Cancer
06/14/2022
Epigallocatechin-3-gallate plus radiotherapy reduced radiation-induced dermatitis vs radiotherapy alone among patients with breast cancer in a phase 2 study.
Epigallocatechin-3-gallate plus radiotherapy reduced radiation-induced dermatitis vs radiotherapy alone among patients with breast cancer in a phase 2 study.
Epigallocatechin-3-gallate plus...
06/14/2022
Oncology
News
Reflectance Confocal Microscopy Reduces Unnecessary Excision and Assures Removal of Aggressive Melanomas
06/13/2022
Adjunctive use of reflectance confocal microscopy for suspect lesions reduces unnecessary excisions and assures the removal of aggressive melanomas.
Adjunctive use of reflectance confocal microscopy for suspect lesions reduces unnecessary excisions and assures the removal of aggressive melanomas.
Adjunctive use of reflectance...
06/13/2022
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement